Differential Expression of the Tetraspanin CD9 in Normal and Leukemic Stem Cells
CD9 plays a crucial role in cellular growth, mobility, and signal transduction, as well as in hematological malignancy. In myeloid neoplasms, CD9 is involved in the altered interactions between leukemic and stromal cells. However, apart from its role in CD34+ progenitors and myeloid and megakaryocyt...
Saved in:
| Published in | Biology (Basel, Switzerland) Vol. 10; no. 4; p. 312 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Switzerland
MDPI AG
08.04.2021
MDPI |
| Subjects | |
| Online Access | Get full text |
| ISSN | 2079-7737 2079-7737 |
| DOI | 10.3390/biology10040312 |
Cover
Loading…
| Abstract | CD9 plays a crucial role in cellular growth, mobility, and signal transduction, as well as in hematological malignancy. In myeloid neoplasms, CD9 is involved in the altered interactions between leukemic and stromal cells. However, apart from its role in CD34+ progenitors and myeloid and megakaryocytic differentiation, its function in normal and leukemic pluripotent cells has not yet been determined. Very small embryonic-like stem cells (VSELs) are promising pluripotent stem cells found in adult tissues that can be developed for safe and efficient regenerative medicine. VSELs express different surface receptors of the highest importance in cell functioning, including CD9, and can be effectively mobilized after organ injury or in leukemic patients. In the present study, we observed that CD9 is among the most expressed receptors in VSELs under steady-state conditions; however, once the VSELs are expanded, CD9+ VSELs decrease and are more apoptotic. CD9– VSELs had no proliferative improvement in vitro compared to those that were CD9+. Interestingly, the addition of SDF-1 induced CD9 expression on the surface of VSELs, as observed by flow cytometry, and improved their migration. In addition, we observed, in the phenotypically identical VSELs present in the peripheral blood of patients with myeloproliferative neoplasms, compared to healthy subjects, a significantly higher number of CD9+ cells. However, in their hematopoietic stem cell (HSC) counterparts, the expression remained comparable. These results indicate that, likewise, in progenitors and mature cells, CD9 may play an important function in normal and malignant VSELs. This could explain the refractoriness observed by some groups of expanded stem cells to repairing efficiently damaged tissue when used as a source in cell therapies. Understanding the function of the CD9 receptor in normal and malignant CD34+ and VSELs, along with its relationship with the CXCR4/SDF-1 pathway, will enable advances in the field of adult pluripotent cell usage in regenerative medicine and in their role in leukemia. |
|---|---|
| AbstractList | Simple SummaryBefore their use in regenerative medicine, stem cells need to be expanded to obtain sufficient cells for the efficient reparation of the injured tissues. This expansion must not affect their integrity. Regarding the role played by different receptors, we observed that, during their expansion, the number of promising pluripotent stem cells found in adult tissues, i.e., very small embryonic-like stem cells (VSELs), which express the CD9 receptor, decreased. This is due to their higher mortality rate compared to that of those not expressing CD9, which can lead to low regenerative efficiency for injured tissues. Interestingly, this could be overcome by the addition of a specific growth factor, allowing the re-establishment of their function. Finally, we found that the expression of this receptor is also deregulated in cells phenotypically identical to VSELs isolated from leukemic patients, which attests to the instability of its expression and may explain disease progression.AbstractCD9 plays a crucial role in cellular growth, mobility, and signal transduction, as well as in hematological malignancy. In myeloid neoplasms, CD9 is involved in the altered interactions between leukemic and stromal cells. However, apart from its role in CD34+ progenitors and myeloid and megakaryocytic differentiation, its function in normal and leukemic pluripotent cells has not yet been determined. Very small embryonic-like stem cells (VSELs) are promising pluripotent stem cells found in adult tissues that can be developed for safe and efficient regenerative medicine. VSELs express different surface receptors of the highest importance in cell functioning, including CD9, and can be effectively mobilized after organ injury or in leukemic patients. In the present study, we observed that CD9 is among the most expressed receptors in VSELs under steady-state conditions; however, once the VSELs are expanded, CD9+ VSELs decrease and are more apoptotic. CD9– VSELs had no proliferative improvement in vitro compared to those that were CD9+. Interestingly, the addition of SDF-1 induced CD9 expression on the surface of VSELs, as observed by flow cytometry, and improved their migration. In addition, we observed, in the phenotypically identical VSELs present in the peripheral blood of patients with myeloproliferative neoplasms, compared to healthy subjects, a significantly higher number of CD9+ cells. However, in their hematopoietic stem cell (HSC) counterparts, the expression remained comparable. These results indicate that, likewise, in progenitors and mature cells, CD9 may play an important function in normal and malignant VSELs. This could explain the refractoriness observed by some groups of expanded stem cells to repairing efficiently damaged tissue when used as a source in cell therapies. Understanding the function of the CD9 receptor in normal and malignant CD34+ and VSELs, along with its relationship with the CXCR4/SDF-1 pathway, will enable advances in the field of adult pluripotent cell usage in regenerative medicine and in their role in leukemia. CD9 plays a crucial role in cellular growth, mobility, and signal transduction, as well as in hematological malignancy. In myeloid neoplasms, CD9 is involved in the altered interactions between leukemic and stromal cells. However, apart from its role in CD34+ progenitors and myeloid and megakaryocytic differentiation, its function in normal and leukemic pluripotent cells has not yet been determined. Very small embryonic-like stem cells (VSELs) are promising pluripotent stem cells found in adult tissues that can be developed for safe and efficient regenerative medicine. VSELs express different surface receptors of the highest importance in cell functioning, including CD9, and can be effectively mobilized after organ injury or in leukemic patients. In the present study, we observed that CD9 is among the most expressed receptors in VSELs under steady-state conditions; however, once the VSELs are expanded, CD9+ VSELs decrease and are more apoptotic. CD9– VSELs had no proliferative improvement in vitro compared to those that were CD9+. Interestingly, the addition of SDF-1 induced CD9 expression on the surface of VSELs, as observed by flow cytometry, and improved their migration. In addition, we observed, in the phenotypically identical VSELs present in the peripheral blood of patients with myeloproliferative neoplasms, compared to healthy subjects, a significantly higher number of CD9+ cells. However, in their hematopoietic stem cell (HSC) counterparts, the expression remained comparable. These results indicate that, likewise, in progenitors and mature cells, CD9 may play an important function in normal and malignant VSELs. This could explain the refractoriness observed by some groups of expanded stem cells to repairing efficiently damaged tissue when used as a source in cell therapies. Understanding the function of the CD9 receptor in normal and malignant CD34+ and VSELs, along with its relationship with the CXCR4/SDF-1 pathway, will enable advances in the field of adult pluripotent cell usage in regenerative medicine and in their role in leukemia. CD9 plays a crucial role in cellular growth, mobility, and signal transduction, as well as in hematological malignancy. In myeloid neoplasms, CD9 is involved in the altered interactions between leukemic and stromal cells. However, apart from its role in CD34+ progenitors and myeloid and megakaryocytic differentiation, its function in normal and leukemic pluripotent cells has not yet been determined. Very small embryonic-like stem cells (VSELs) are promising pluripotent stem cells found in adult tissues that can be developed for safe and efficient regenerative medicine. VSELs express different surface receptors of the highest importance in cell functioning, including CD9, and can be effectively mobilized after organ injury or in leukemic patients. In the present study, we observed that CD9 is among the most expressed receptors in VSELs under steady-state conditions; however, once the VSELs are expanded, CD9+ VSELs decrease and are more apoptotic. CD9- VSELs had no proliferative improvement in vitro compared to those that were CD9+. Interestingly, the addition of SDF-1 induced CD9 expression on the surface of VSELs, as observed by flow cytometry, and improved their migration. In addition, we observed, in the phenotypically identical VSELs present in the peripheral blood of patients with myeloproliferative neoplasms, compared to healthy subjects, a significantly higher number of CD9+ cells. However, in their hematopoietic stem cell (HSC) counterparts, the expression remained comparable. These results indicate that, likewise, in progenitors and mature cells, CD9 may play an important function in normal and malignant VSELs. This could explain the refractoriness observed by some groups of expanded stem cells to repairing efficiently damaged tissue when used as a source in cell therapies. Understanding the function of the CD9 receptor in normal and malignant CD34+ and VSELs, along with its relationship with the CXCR4/SDF-1 pathway, will enable advances in the field of adult pluripotent cell usage in regenerative medicine and in their role in leukemia.CD9 plays a crucial role in cellular growth, mobility, and signal transduction, as well as in hematological malignancy. In myeloid neoplasms, CD9 is involved in the altered interactions between leukemic and stromal cells. However, apart from its role in CD34+ progenitors and myeloid and megakaryocytic differentiation, its function in normal and leukemic pluripotent cells has not yet been determined. Very small embryonic-like stem cells (VSELs) are promising pluripotent stem cells found in adult tissues that can be developed for safe and efficient regenerative medicine. VSELs express different surface receptors of the highest importance in cell functioning, including CD9, and can be effectively mobilized after organ injury or in leukemic patients. In the present study, we observed that CD9 is among the most expressed receptors in VSELs under steady-state conditions; however, once the VSELs are expanded, CD9+ VSELs decrease and are more apoptotic. CD9- VSELs had no proliferative improvement in vitro compared to those that were CD9+. Interestingly, the addition of SDF-1 induced CD9 expression on the surface of VSELs, as observed by flow cytometry, and improved their migration. In addition, we observed, in the phenotypically identical VSELs present in the peripheral blood of patients with myeloproliferative neoplasms, compared to healthy subjects, a significantly higher number of CD9+ cells. However, in their hematopoietic stem cell (HSC) counterparts, the expression remained comparable. These results indicate that, likewise, in progenitors and mature cells, CD9 may play an important function in normal and malignant VSELs. This could explain the refractoriness observed by some groups of expanded stem cells to repairing efficiently damaged tissue when used as a source in cell therapies. Understanding the function of the CD9 receptor in normal and malignant CD34+ and VSELs, along with its relationship with the CXCR4/SDF-1 pathway, will enable advances in the field of adult pluripotent cell usage in regenerative medicine and in their role in leukemia. CD9 plays a crucial role in cellular growth, mobility, and signal transduction, as well as in hematological malignancy. In myeloid neoplasms, CD9 is involved in the altered interactions between leukemic and stromal cells. However, apart from its role in CD34⁺ progenitors and myeloid and megakaryocytic differentiation, its function in normal and leukemic pluripotent cells has not yet been determined. Very small embryonic-like stem cells (VSELs) are promising pluripotent stem cells found in adult tissues that can be developed for safe and efficient regenerative medicine. VSELs express different surface receptors of the highest importance in cell functioning, including CD9, and can be effectively mobilized after organ injury or in leukemic patients. In the present study, we observed that CD9 is among the most expressed receptors in VSELs under steady-state conditions; however, once the VSELs are expanded, CD9⁺ VSELs decrease and are more apoptotic. CD9– VSELs had no proliferative improvement in vitro compared to those that were CD9⁺. Interestingly, the addition of SDF-1 induced CD9 expression on the surface of VSELs, as observed by flow cytometry, and improved their migration. In addition, we observed, in the phenotypically identical VSELs present in the peripheral blood of patients with myeloproliferative neoplasms, compared to healthy subjects, a significantly higher number of CD9⁺ cells. However, in their hematopoietic stem cell (HSC) counterparts, the expression remained comparable. These results indicate that, likewise, in progenitors and mature cells, CD9 may play an important function in normal and malignant VSELs. This could explain the refractoriness observed by some groups of expanded stem cells to repairing efficiently damaged tissue when used as a source in cell therapies. Understanding the function of the CD9 receptor in normal and malignant CD34⁺ and VSELs, along with its relationship with the CXCR4/SDF-1 pathway, will enable advances in the field of adult pluripotent cell usage in regenerative medicine and in their role in leukemia. CD9 plays a crucial role in cellular growth, mobility, and signal transduction, as well as in hematological malignancy. In myeloid neoplasms, CD9 is involved in the altered interactions between leukemic and stromal cells. However, apart from its role in CD34 progenitors and myeloid and megakaryocytic differentiation, its function in normal and leukemic pluripotent cells has not yet been determined. Very small embryonic-like stem cells (VSELs) are promising pluripotent stem cells found in adult tissues that can be developed for safe and efficient regenerative medicine. VSELs express different surface receptors of the highest importance in cell functioning, including CD9, and can be effectively mobilized after organ injury or in leukemic patients. In the present study, we observed that CD9 is among the most expressed receptors in VSELs under steady-state conditions; however, once the VSELs are expanded, CD9 VSELs decrease and are more apoptotic. CD9 VSELs had no proliferative improvement in vitro compared to those that were CD9 . Interestingly, the addition of SDF-1 induced CD9 expression on the surface of VSELs, as observed by flow cytometry, and improved their migration. In addition, we observed, in the phenotypically identical VSELs present in the peripheral blood of patients with myeloproliferative neoplasms, compared to healthy subjects, a significantly higher number of CD9 cells. However, in their hematopoietic stem cell (HSC) counterparts, the expression remained comparable. These results indicate that, likewise, in progenitors and mature cells, CD9 may play an important function in normal and malignant VSELs. This could explain the refractoriness observed by some groups of expanded stem cells to repairing efficiently damaged tissue when used as a source in cell therapies. Understanding the function of the CD9 receptor in normal and malignant CD34 and VSELs, along with its relationship with the CXCR4/SDF-1 pathway, will enable advances in the field of adult pluripotent cell usage in regenerative medicine and in their role in leukemia. |
| Author | Hénon, Philippe Scrofani, Maurice Drénou, Bernard Lahlil, Rachid Aries, Anne |
| AuthorAffiliation | 1 Institut de Recherche en Hématologie et Transplantation (IRHT), Hôpital du Hasenrain, 87 Avenue d’Altkirch, 68100 Mulhouse, France; scofanim@ghrmsa.fr (M.S.); ariesa@ghrmsa.fr (A.A.); DRENOUB@ghrmsa.fr (B.D.) 2 CellProthera, 12, rue du Parc, 68100 Mulhouse, France; phenon@cellprothera.com 3 Laboratoire d’Hématologie, Groupe Hospitalier de la Région de Mulhouse Sud-Alsace, Hôpital E. Muller, 20 Avenue de Dr Laennec, 68100 Mulhouse, France |
| AuthorAffiliation_xml | – name: 3 Laboratoire d’Hématologie, Groupe Hospitalier de la Région de Mulhouse Sud-Alsace, Hôpital E. Muller, 20 Avenue de Dr Laennec, 68100 Mulhouse, France – name: 1 Institut de Recherche en Hématologie et Transplantation (IRHT), Hôpital du Hasenrain, 87 Avenue d’Altkirch, 68100 Mulhouse, France; scofanim@ghrmsa.fr (M.S.); ariesa@ghrmsa.fr (A.A.); DRENOUB@ghrmsa.fr (B.D.) – name: 2 CellProthera, 12, rue du Parc, 68100 Mulhouse, France; phenon@cellprothera.com |
| Author_xml | – sequence: 1 givenname: Rachid orcidid: 0000-0003-2966-6386 surname: Lahlil fullname: Lahlil, Rachid – sequence: 2 givenname: Maurice surname: Scrofani fullname: Scrofani, Maurice – sequence: 3 givenname: Anne surname: Aries fullname: Aries, Anne – sequence: 4 givenname: Philippe surname: Hénon fullname: Hénon, Philippe – sequence: 5 givenname: Bernard orcidid: 0000-0002-2175-6785 surname: Drénou fullname: Drénou, Bernard |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33918035$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNks1vFCEYh4mpsbX27M1M4qWXtXwzXEzMtmqTjZpYz4TPLesMrDBj7H8v261N25NcXgIPT15-8BIcpJw8AK8RfEeIhGcm5iGvbxCEFBKEn4EjDIVcCEHEwYP5ITipdQPbEBBzwl-Aw3Yc9ZCwI_DtPIbgi09T1EN38WdbfK0xpy6Hbrr23ZWfiq5bnWLqlueya-VLLmNjdXLdys8__Rht933yY7f0w1BfgedBD9Wf3NVj8OPjxdXy82L19dPl8sNqYamg00IYBq2nyDDMAqOEQip9YEFQjzCWjhhmaTCst7zdASPKjOOCY4wDxc5icgwu916X9UZtSxx1uVFZR3W7kMta6TJFO3gFjek9YY5owylxziDjHJc9I4Fzh2Fzvd-7trMZvbMtjaKHR9LHOyleq3X-rfrbSEUTnN4JSv41-zqpMVbb4tDJ57kqzBiSveQM_geKYc8JFrKhb5-gmzyX1FLdUT2WQsKd8M3D5u-7_vfGDTjbA7bkWosP9wiCOwqqJx-J_AVgHLn0 |
| Cites_doi | 10.1038/31269 10.1002/cam4.2007 10.1016/S0898-6568(02)00147-X 10.1182/blood-2015-02-628560 10.1007/s12015-018-9821-1 10.1634/stemcells.2006-0351 10.3324/haematol.2014.118497 10.1182/blood-2016-03-643544 10.1038/s41568-020-0260-3 10.1007/s12015-017-9732-6 10.1161/CIRCRESAHA.116.309362 10.1016/j.exphem.2011.08.012 10.3233/CBM-170422 10.1073/pnas.96.10.5663 10.1186/s13287-015-0041-1 10.1089/scd.2014.0142 10.1007/s12015-017-9731-7 10.1038/s41556-019-0344-z 10.1155/2016/7651645 10.1182/blood.V97.10.3283 10.1038/sj.leu.2404171 10.1016/j.bbrc.2011.04.098 10.2478/v10039-012-0020-z 10.1002/jcb.24427 10.1002/path.4066 10.1016/j.leukres.2009.09.033 10.1111/j.1582-4934.2010.01126.x 10.1126/science.283.5403.845 10.1016/j.exphem.2011.01.003 10.1038/sj.leu.2404343 10.1634/stemcells.2007-0715 10.1182/blood-2010-04-281329 10.1016/j.celrep.2013.07.020 10.1002/sctm.17-0048 10.1155/2018/1943980 |
| ContentType | Journal Article |
| Copyright | 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2021 by the authors. 2021 |
| Copyright_xml | – notice: 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2021 by the authors. 2021 |
| DBID | AAYXX CITATION NPM 7QP 7TK 8FD 8FE 8FH ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 GNUQQ HCIFZ LK8 M7P P64 PHGZM PHGZT PIMPY PKEHL PQEST PQGLB PQQKQ PQUKI PRINS RC3 7X8 7S9 L.6 5PM DOA |
| DOI | 10.3390/biology10040312 |
| DatabaseName | CrossRef PubMed Calcium & Calcified Tissue Abstracts Neurosciences Abstracts Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Engineering Research Database ProQuest Central Student SciTech Premium Collection ProQuest Biological Science Collection Biological Science Database Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Genetics Abstracts MEDLINE - Academic AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals (DOAJ) |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences Genetics Abstracts Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Central (New) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts Biotechnology and BioEngineering Abstracts ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic AGRICOLA CrossRef PubMed |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology Medicine |
| EISSN | 2079-7737 |
| ExternalDocumentID | oai_doaj_org_article_0bb8e35d3ab643ddb1bdd69853f66d20 PMC8070267 33918035 10_3390_biology10040312 |
| Genre | Journal Article |
| GeographicLocations | France |
| GeographicLocations_xml | – name: France |
| GroupedDBID | 2XV 53G 5VS 8FE 8FH AADQD AAFWJ AAHBH AAYXX ADBBV AFKRA AFPKN AFZYC ALMA_UNASSIGNED_HOLDINGS AOIJS BBNVY BCNDV BENPR BHPHI CCPQU CITATION EBD GROUPED_DOAJ HCIFZ HYE IAO IHR ITC KQ8 LK8 M48 M7P MODMG M~E OK1 PGMZT PHGZM PHGZT PIMPY PROAC RPM NPM 7QP 7TK 8FD ABUWG AZQEC DWQXO FR3 GNUQQ P64 PKEHL PQEST PQGLB PQQKQ PQUKI PRINS RC3 7X8 7S9 L.6 5PM PUEGO |
| ID | FETCH-LOGICAL-c474t-7b50ce41b525f5434049ef5f74e1229d3b5c4fb58c67732145bd676222f42dc23 |
| IEDL.DBID | M48 |
| ISSN | 2079-7737 |
| IngestDate | Wed Aug 27 01:34:00 EDT 2025 Thu Aug 21 14:05:31 EDT 2025 Thu Jul 10 22:22:48 EDT 2025 Fri Jul 11 11:36:48 EDT 2025 Fri Jul 25 12:00:30 EDT 2025 Thu Apr 03 06:58:03 EDT 2025 Tue Jul 01 01:28:35 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Keywords | leukemia CD9 umbilical cord blood CD34+/CD133+/CXCR4+ cells VSELs human very small embryonic-like stem cells |
| Language | English |
| License | https://creativecommons.org/licenses/by/4.0 Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c474t-7b50ce41b525f5434049ef5f74e1229d3b5c4fb58c67732145bd676222f42dc23 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0002-2175-6785 0000-0003-2966-6386 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/biology10040312 |
| PMID | 33918035 |
| PQID | 2528297900 |
| PQPubID | 2032427 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_0bb8e35d3ab643ddb1bdd69853f66d20 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8070267 proquest_miscellaneous_2551989650 proquest_miscellaneous_2520863279 proquest_journals_2528297900 pubmed_primary_33918035 crossref_primary_10_3390_biology10040312 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 20210408 |
| PublicationDateYYYYMMDD | 2021-04-08 |
| PublicationDate_xml | – month: 4 year: 2021 text: 20210408 day: 8 |
| PublicationDecade | 2020 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland – name: Basel |
| PublicationTitle | Biology (Basel, Switzerland) |
| PublicationTitleAlternate | Biology (Basel) |
| PublicationYear | 2021 |
| Publisher | MDPI AG MDPI |
| Publisher_xml | – name: MDPI AG – name: MDPI |
| References | Desterke (ref_22) 2015; 100 Arber (ref_25) 2016; 127 Sovalat (ref_6) 2011; 39 Psatha (ref_30) 2017; 6 Andersen (ref_18) 2006; 20 Yunta (ref_17) 2003; 15 Ratajczak (ref_16) 2017; 120 Gandemer (ref_23) 2010; 34 Yamazaki (ref_34) 2011; 409 Dawn (ref_7) 2008; 26 Garayoa (ref_33) 2013; 229 Kawabata (ref_32) 1999; 96 Liang (ref_27) 2018; 21 Touzet (ref_35) 2019; 8 Sovalat (ref_11) 2016; 2016 Peled (ref_28) 1999; 283 Eljaszewicz (ref_13) 2018; 2018 Guerin (ref_10) 2017; 13 Kollet (ref_31) 2001; 97 Leung (ref_19) 2011; 117 Guglielmelli (ref_21) 2007; 25 Guo (ref_8) 2011; 15 Shivtiel (ref_29) 2011; 39 Guerin (ref_12) 2017; 13 Kucia (ref_5) 2006; 20 Lee (ref_9) 2014; 23 Yamashita (ref_36) 2020; 20 Zou (ref_37) 1998; 393 Aiuti (ref_1) 2019; 21 Yoo (ref_4) 2013; 114 Brzoska (ref_26) 2015; 6 Lahlil (ref_14) 2020; 6 Arnaud (ref_24) 2015; 126 Larijani (ref_3) 2012; 50 Ratajczak (ref_2) 2012; 57 Karlsson (ref_20) 2013; 4 Lahlil (ref_15) 2018; 14 |
| References_xml | – volume: 393 start-page: 595 year: 1998 ident: ref_37 article-title: Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development publication-title: Nature doi: 10.1038/31269 – volume: 8 start-page: 1279 year: 2019 ident: ref_35 article-title: CD9 in acute myeloid leukemia: Prognostic role and usefulness to target leukemic stem cells publication-title: Cancer Med. doi: 10.1002/cam4.2007 – volume: 15 start-page: 559 year: 2003 ident: ref_17 article-title: Tetraspanin proteins as organisers of membrane microdomains and signalling complexes publication-title: Cell. Signal. doi: 10.1016/S0898-6568(02)00147-X – volume: 126 start-page: 1802 year: 2015 ident: ref_24 article-title: CD9, a key actor in the dissemination of lymphoblastic leukemia, modulating CXCR4-mediated migration via RAC1 signaling publication-title: Blood doi: 10.1182/blood-2015-02-628560 – volume: 50 start-page: 79 year: 2012 ident: ref_3 article-title: Stem Cell Therapy in Treatment of Different Diseases publication-title: Acta Med. Iran. – volume: 14 start-page: 510 year: 2018 ident: ref_15 article-title: VSELs Maintain their Pluripotency and Competence to Differentiate after Enhanced Ex Vivo Expansion publication-title: Stem Cell Rev. Rep. doi: 10.1007/s12015-018-9821-1 – volume: 25 start-page: 165 year: 2007 ident: ref_21 article-title: Molecular Profiling of CD34+ Cells in Idiopathic Myelofibrosis Identifies a Set of Disease-Associated Genes and Reveals the Clinical Significance of Wilms’ Tumor Gene 1 (WT1) publication-title: Stem Cells doi: 10.1634/stemcells.2006-0351 – volume: 100 start-page: 757 year: 2015 ident: ref_22 article-title: Tetraspanin CD9 participates in dysmegakaryopoiesis and stromal interactions in primary myelofibrosis publication-title: Haematologica doi: 10.3324/haematol.2014.118497 – volume: 127 start-page: 2391 year: 2016 ident: ref_25 article-title: The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia publication-title: Blood doi: 10.1182/blood-2016-03-643544 – volume: 20 start-page: 365 year: 2020 ident: ref_36 article-title: Dysregulated haematopoietic stem cell behaviour in myeloid leukaemogenesis publication-title: Nat. Rev. Cancer doi: 10.1038/s41568-020-0260-3 – volume: 13 start-page: 561 year: 2017 ident: ref_12 article-title: Very Small Embryonic-like Stem Cells Are Mobilized in Human Peripheral Blood during Hypoxemic COPD Exacerbations and Pulmonary Hypertension publication-title: Stem Cell Rev. Rep. doi: 10.1007/s12015-017-9732-6 – volume: 120 start-page: 166 year: 2017 ident: ref_16 article-title: A Novel View of the Adult Stem Cell Compartment from the Perspective of a Quiescent Population of Very Small Embryonic-Like Stem Cells publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.116.309362 – volume: 6 start-page: 1 year: 2020 ident: ref_14 article-title: CD34+ Very Small Embryonic-like Stem Cells or Induced Pluripotent Stem Cells for Cardiac Repair? publication-title: J. Cardiol. Vasc. Med. – volume: 39 start-page: 1161 year: 2011 ident: ref_29 article-title: CD45 regulates homing and engraftment of immature normal and leukemic human cells in transplanted immunodeficient mice publication-title: Exp. Hematol. doi: 10.1016/j.exphem.2011.08.012 – volume: 21 start-page: 781 year: 2018 ident: ref_27 article-title: CD9 expression indicates a poor outcome in acute lymphoblastic leukemia publication-title: Cancer Biomark. doi: 10.3233/CBM-170422 – volume: 96 start-page: 5663 year: 1999 ident: ref_32 article-title: A cell-autonomous requirement for CXCR4 in long-term lymphoid and myeloid reconstitution publication-title: Proc. Natl. Acad. Sci. USA doi: 10.1073/pnas.96.10.5663 – volume: 6 start-page: 46 year: 2015 ident: ref_26 article-title: Sdf-1 (CXCL12) induces CD9 expression in stem cells engaged in muscle regeneration publication-title: Stem Cell Res. Ther. doi: 10.1186/s13287-015-0041-1 – volume: 23 start-page: 2831 year: 2014 ident: ref_9 article-title: Adult Stem Cells from the Hyaluronic Acid-Rich Node and Duct System Differentiate into Neuronal Cells and Repair Brain Injury publication-title: Stem Cells Dev. doi: 10.1089/scd.2014.0142 – volume: 13 start-page: 552 year: 2017 ident: ref_10 article-title: Human very Small Embryonic-like Cells Support Vascular Maturation and Therapeutic Revascularization Induced by Endothelial Progenitor Cells publication-title: Stem Cell Rev. Rep. doi: 10.1007/s12015-017-9731-7 – volume: 21 start-page: 801 year: 2019 ident: ref_1 article-title: Advances in stem cell research and therapeutic development publication-title: Nat. Cell Biol. doi: 10.1038/s41556-019-0344-z – volume: 2016 start-page: 7651645 year: 2016 ident: ref_11 article-title: Human Very Small Embryonic-Like Stem Cells Are Present in Normal Peripheral Blood of Young, Middle-Aged, and Aged Subjects publication-title: Stem Cells Int. doi: 10.1155/2016/7651645 – volume: 97 start-page: 3283 year: 2001 ident: ref_31 article-title: Rapid and efficient homing of human CD34+CD38−/lowCXCR4+ stem and progenitor cells to the bone marrow and spleen of NOD/SCID and NOD/SCID/B2mnull mice publication-title: Blood doi: 10.1182/blood.V97.10.3283 – volume: 20 start-page: 857 year: 2006 ident: ref_5 article-title: A population of very small embryonic-like (VSEL) CXCR4+SSEA-1+Oct-4+ stem cells identified in adult bone marrow publication-title: Leukemia doi: 10.1038/sj.leu.2404171 – volume: 409 start-page: 14 year: 2011 ident: ref_34 article-title: Regulation of cancer stem cell properties by CD9 in human B-acute lymphoblastic leukemia publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2011.04.098 – volume: 57 start-page: 1 year: 2012 ident: ref_2 article-title: Pluripotent and multipotent stem cells in adult tissues publication-title: Adv. Med. Sci. doi: 10.2478/v10039-012-0020-z – volume: 114 start-page: 743 year: 2013 ident: ref_4 article-title: Stem cells as promising therapeutic options for neurological disorders publication-title: J. Cell. Biochem. doi: 10.1002/jcb.24427 – volume: 229 start-page: 36 year: 2013 ident: ref_33 article-title: Sphingosine-1-phosphate activates chemokine-promoted myeloma cell adhesion and migration involving α4β1 integrin function publication-title: J. Pathol. doi: 10.1002/path.4066 – volume: 34 start-page: 430 year: 2010 ident: ref_23 article-title: CD9 expression can be used to predict childhood TEL/AML1-positive acute lymphoblastic leukemia: Proposal for an accelerated diagnostic flowchart publication-title: Leuk. Res. doi: 10.1016/j.leukres.2009.09.033 – volume: 15 start-page: 1319 year: 2011 ident: ref_8 article-title: Transplantation of expanded bone marrow-derived very small embryonic-like stem cells (VSEL-SCs) improves left ventricular function and remodelling after myocardial infarction publication-title: J. Cell. Mol. Med. doi: 10.1111/j.1582-4934.2010.01126.x – volume: 283 start-page: 845 year: 1999 ident: ref_28 article-title: Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4 publication-title: Science doi: 10.1126/science.283.5403.845 – volume: 39 start-page: 495 year: 2011 ident: ref_6 article-title: Identification and isolation from either adult human bone marrow or G-CSF−mobilized peripheral blood of CD34+/CD133+/CXCR4+/ Lin−CD45− cells, featuring morphological, molecular, and phenotypic characteristics of very small embryonic-like (VSEL) stem cells publication-title: Exp. Hematol. doi: 10.1016/j.exphem.2011.01.003 – volume: 20 start-page: 1870 year: 2006 ident: ref_18 article-title: Endothelial cell-driven regulation of CD9 or motility-related protein-1 expression in multiple myeloma cells within the murine 5T33MM model and myeloma patients publication-title: Leukemia doi: 10.1038/sj.leu.2404343 – volume: 26 start-page: 1646 year: 2008 ident: ref_7 article-title: Transplantation of Bone Marrow-Derived Very Small Embryonic-Like Stem Cells Attenuates Left Ventricular Dysfunction and Remodeling After Myocardial Infarction publication-title: Stem Cells doi: 10.1634/stemcells.2007-0715 – volume: 117 start-page: 1840 year: 2011 ident: ref_19 article-title: The tetraspanin CD9 regulates migration, adhesion, and homing of human cord blood CD34+ hematopoietic stem and progenitor cells publication-title: Blood doi: 10.1182/blood-2010-04-281329 – volume: 4 start-page: 642 year: 2013 ident: ref_20 article-title: The Tetraspanin CD9 Affords High-Purity Capture of All Murine Hematopoietic Stem Cells publication-title: Cell Rep. doi: 10.1016/j.celrep.2013.07.020 – volume: 6 start-page: 1852 year: 2017 ident: ref_30 article-title: Brief Report: A Differential Transcriptomic Profile of Ex Vivo Expanded Adult Human Hematopoietic Stem Cells Empowers Them for Engraftment Better than Their Surface Phenotype: Ex Vivo Expansion of Adult HSCs publication-title: Stem Cells Transl. Med. doi: 10.1002/sctm.17-0048 – volume: 2018 start-page: 1943980 year: 2018 ident: ref_13 article-title: Very Small Embryonic-Like Stem Cells, Endothelial Progenitor Cells, and Different Monocyte Subsets Are Effectively Mobilized in Acute Lymphoblastic Leukemia Patients after G-CSF Treatment publication-title: Stem Cells Int. doi: 10.1155/2018/1943980 |
| SSID | ssj0000702636 |
| Score | 2.1951964 |
| Snippet | CD9 plays a crucial role in cellular growth, mobility, and signal transduction, as well as in hematological malignancy. In myeloid neoplasms, CD9 is involved... Simple SummaryBefore their use in regenerative medicine, stem cells need to be expanded to obtain sufficient cells for the efficient reparation of the injured... |
| SourceID | doaj pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database |
| StartPage | 312 |
| SubjectTerms | adults Apoptosis Blood Bone marrow CD34 antigen CD34+/CD133+/CXCR4+ cells CD9 CD9 antigen cell growth Cloning CXCR4 protein Embryo cells Flow cytometry Gene amplification gene expression regulation Generalized linear models Genomics Hematopoietic stem cells human very small embryonic-like stem cells Leukemia Malignancy Medical research medicine Neoplasia Peripheral blood Pluripotency Regenerative medicine SDF-1 protein Signal transduction Stem cells Stromal cells Tumors Umbilical cord umbilical cord blood VSELs |
| SummonAdditionalLinks | – databaseName: Directory of Open Access Journals (DOAJ) dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEA4iCF7Et_VFBA9eim2aNM1R1xURFUEFb6VppiiuWXF3Qf-9M2132RXRi6dCk5RkZpKZj0y_YexQmky6OIGwUAYBCnr00ETShaku0f0VpUsKAorXN-nFg7x8VI9Tpb4oJ6yhB24EdxxZm0GicIxF5-mcja1zqUEvU6WpEzVaR583BabqM1gjtqB7SeLySRDXH7ecRkSQhnYsZtxQzdb_U4j5PVNyyvWcL7OlNmbkJ81cV9gc-FW20FSR_Fxjt2dtkRPcrD3e_WhTWz3vVxzDO34P-FE8OPyz550zw_FxQ5Fqjxfe8SsYvVCCPL8bwivvQK83WGcP5937zkXYFkoIS6nlMNRWRSXI2CqhKvpXFMN-qFSlJcRCGJdYVcrKqqxMtabKRMq6FE9BISopXCmSDTbv-x62GJcaBa6MsREOgTi2BQBu0yJzUsoITMCOxnLL3xo-jBxxBIk4_ybigJ2SXCfdiMi6foHqzVv15n-pN2C7Y63k7e4a5ELR_a82ETYfTJpxX9BlR-GhP6r7IFpLhDa_9VGUMoZBasA2G0VPZosrirMoUQHTMyYws5zZFv_8VPNzZ7X16e3_WP8OWxSURUO5Qtkumx--j2APw6Ch3a8t_gtR_AYU priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT9swED9tIKS9TLABy4DJk_awlwjHseP4CUEpQtNWoQ0k3qI4dja0zmG0lbb_nrvU7SiaeIoUO4l9vo_f2Zc7gA_SlNJluU9rZdBBQYueGi5dWugGzV_duLwmR_HLqDi_kp-u1XXccJvEsMqFTuwVtesa2iM_FIrO_LTh_Oj2d0pVo-h0NZbQeA7rqIJL5PD1k-Ho4utylwUZWhR0Pkk5fXL07w9jbiNKlIb8LFbMUZ-1_39Q83HE5AMTdLYJLyN2ZMfzxd6CZz68go15Ncm_r-HiNBY7QaEds-GfGOIaWNcyhHns0uNLUYGEm8AGp4bhZUSIdczq4NhnP_tJgfLs29T_YgM_Hk-24epseDk4T2PBhLSRWk5TbRVvvMysEqqlf0YR_vtWtVr6TAjjcqsa2VpVNoXWVKFIWVegNhSilcI1It-BtdAF_waY1NxaZYzl-IjPMlt7j-Jal05Kyb1J4OOCbtXtPC9Ghf4Ekbh6ROIEToiuy26U0Lq_0d19r6J8VPi10ucKWcMiRnLOZta5wiCYaIvCCZ7A_mJVqihlk-ofTyTwftmM8kGHHnXw3azvg15bLrR5qo-i0DEEqwnszhd6OVqcUVbyXCWgV1hgZTqrLeHmR5-nu-y5T799euh78EJQnAxFA5X7sDa9m_kDBDpT-y5y8z1rVP4h priority: 102 providerName: ProQuest |
| Title | Differential Expression of the Tetraspanin CD9 in Normal and Leukemic Stem Cells |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/33918035 https://www.proquest.com/docview/2528297900 https://www.proquest.com/docview/2520863279 https://www.proquest.com/docview/2551989650 https://pubmed.ncbi.nlm.nih.gov/PMC8070267 https://doaj.org/article/0bb8e35d3ab643ddb1bdd69853f66d20 |
| Volume | 10 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fT9swED5NoE28INjPDKg8aQ97yeY4dhw_oGmUIjSNCm1U4i2KY4chgstKK8F_z9lJy4q6PUWyHSe53Pm-L77cAXzkKucmSW1cCoUEBT16rCg3cSYrdH9lZdLSE8WTYXY84t_PxfljOaBOgLcrqZ2vJzWaNJ_v_tx_RYPf94wTKfuXLl2Rz32GKorr8Tq6JenrOJx0WD8syxLpRigZyKhUiCpT2ab6WTXHBrzA5iSnoQzco8MKef1XgdGnMZV_OamjLdjs0CX51qrDNjyz7iU8b-tN3r-C08OuHAqadUMGd10QrCPjmiAQJGcWJ8Ulxl060j9UBA9Dj2kbUjpDftjZlQ-lJ7-m9pr0bdPcvobR0eCsfxx3JRXiiks-jaUWtLI80YKJ2v9VigTB1qKW3CaMKZNqUfFai7zKUEA-i7k2Ga6XjNWcmYqlb2DNjZ19B4RLqrVQSlM8xSaJLq1Fgy5zwzmnVkXwaS634qbNnFEg4_DSLp5IO4IDL9fFMJ_yOjSMJxdFZ0EFXi23qUDl0YiijNGJNiZTCDfqLDOMRrA7fyvFXI0KJvxOsVQUuz8sutGC_LZI6ex4FsYgr0uZVP8bI3xwGcLZCN62L3pxt3NFiUAuqcDS4yz3uMvfIZN3HpRSvv_nnDuwwXwQjQ8VyndhbTqZ2T1EQVPdg_WDwfD0Zy98RegFXX8AZFEE7g |
| linkProvider | Scholars Portal |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED9NnRC8IL4JDDASSLxESxw7jh8QYm2njnXVBJ20txDHDkzrkrG2gv1T_I3c5aPQCe1tT5ESJ7HPd-ff-c53AG-EToQNI-dnUqOBgiu6rwNh_VjluPxluY0yMhQPJvHoSHw6lscb8Ls7C0NhlZ1OrBW1rXLaI9_mknx-SgfBh_MfPlWNIu9qV0KjYYt9d_kTTbb5-70Bzu9bzneH0_7Ib6sK-LlQYuErI4PcidBILgs6WIkY2RWyUMKFnGsbGZmLwsgkj5WiMj7S2BhVBueF4DanRAeo8jdFhFChB5s7w8nh59WuDgoQj8kfSjmEokgH220uJUrMhvLD15a_ukrA_6Dt1QjNf5a83Xtwt8Wq7GPDXPdhw5UP4FZTvfLyIRwO2uIqqCRmbPirDaktWVUwhJVs6vCjqLDKk5L1B5rhZUIIecay0rKxW55SYD77snBnrO9ms_kjOLoRUj6GXlmV7ikwoQJjpNYmwFdcGJrMOVQPWWKFEIHTHrzr6JaeN3k4UrRfiMTpFRJ7sEN0XTWjBNr1jeriW9rKY4p_S1wkkRUNYjJrTWisjTWClyKOLQ882OpmJW2lep7-5UEPXq8eozySkyUrXbWs26CVGHGlr2sjKVQNwbEHT5qJXvUWRxQmQSQ9UGsssDac9Sflyfc6L3hSc596dn3XX8Ht0fRgnI73JvvP4Q6nGB2KREq2oLe4WLoXCLIW5mXL2Qy-3rQw_QEvRjlX |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB5VW4G4IN5NKWAkkLhEmzh2HB8QovtQS8tqBa3UW4hjByq2SenuCvrX-HXM5LGwFeqtp0iJk9jjmfE3nvEMwCuhE2HDyPmZ1Gig4Iru60BYP1Y5Ln9ZbqOMDMWPk3jvWHw4kScb8Ls7C0NhlZ1OrBW1rXLaI-9zST4_pYOgX7RhEdPh-N35D58qSJGntSun0bDIgbv8iebb_O3-EOf6Nefj0dFgz28rDPi5UGLhKyOD3InQSC4LOmSJeNkVslDChZxrGxmZi8LIJI-VopI-0tgY1QfnheA2p6QHqP43FR0f7cHm7mgy_bTa4UFh4jH5RimfUBTpoN_mVaIkbShLfG0prCsG_A_mXo3W_Gf5G9-Duy1uZe8bRrsPG658ALeaSpaXD2E6bAutoMKYsdGvNry2ZFXBEGKyI4cfReVVnpZsMNQMLxNCyzOWlZYduuV3CtJnnxfujA3cbDZ_BMc3QsrH0Cur0m0BEyowRmptAnzFhaHJnENVkSVWCBE47cGbjm7peZOTI0VbhkicXiGxB7tE11UzSqZd36guvqatbKb4t8RFEtnSID6z1oTG2lgjkCni2PLAg51uVtJWwufpX3704OXqMcomOVyy0lXLug1ajBFX-ro2ksLWECh78KSZ6FVvcURhEkTSA7XGAmvDWX9Snn6rc4QnNfep7eu7_gJuoxClh_uTg6dwh1O4DgUlJTvQW1ws3TPEWwvzvGVsBl9uWpb-AM2OPZU |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Differential+Expression+of+the+Tetraspanin+CD9+in+Normal+and+Leukemic+Stem+Cells&rft.jtitle=Biology+%28Basel%2C+Switzerland%29&rft.au=Lahlil%2C+Rachid&rft.au=Scrofani%2C+Maurice&rft.au=Aries%2C+Anne&rft.au=H%C3%A9non%2C+Philippe&rft.date=2021-04-08&rft.issn=2079-7737&rft.eissn=2079-7737&rft.volume=10&rft.issue=4&rft_id=info:doi/10.3390%2Fbiology10040312&rft_id=info%3Apmid%2F33918035&rft.externalDocID=33918035 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2079-7737&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2079-7737&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2079-7737&client=summon |